BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, May 6, 2026
Home » Authors » John Fox

John Fox

Articles

ARTICLES

Immune suppressive proteins help malaria evade host response

Dec. 18, 2017
By John Fox

Immune suppressive proteins help malaria evade host response

Dec. 18, 2017
By John Fox
The discovery of several new key molecules that are involved in severe Plasmodium falciparum malaria is expected to contribute to the development of effective new vaccines and therapeutic drugs against malaria.
Read More

'Exercise hormone' irisin protects lung tissue

Dec. 6, 2017
By John Fox
HONG KONG – Exercising, it turns out, is good for the lungs in more ways than one.
Read More

'Exercise hormone' irisin protects lung tissue

Dec. 5, 2017
By John Fox

'Exercise hormone' irisin protects lung tissue

Dec. 1, 2017
By John Fox
Exercising, it turns out, is good for the lungs in more ways than one.
Read More

New micro-robots may hold biomedical promise

Nov. 29, 2017
By John Fox
HONG KONG – Scientists report having developed new biohybrid micro-robots capable of navigating complex biological environments with high precision, which potentially have biomedical applications including disease monitoring, targeted drug delivery and minimally invasive surgery.
Read More

New micro-robots may hold biomedical promise

Nov. 28, 2017
By John Fox

New micro-robots may hold biomedical promise

Nov. 28, 2017
By John Fox
HONG KONG – Scientists report having developed new biohybrid micro-robots capable of navigating complex biological environments with high precision, which potentially have biomedical applications including disease monitoring, targeted drug delivery and minimally invasive surgery.
Read More

ER-beta found to play key role in neural stem cell differentiation

Nov. 22, 2017
By John Fox

IL-11 identified as therapeutic target for cardiovascular fibrosis

Nov. 22, 2017
By John Fox
Researchers at Duke-National University of Singapore (Duke-NUS) Medical School have discovered for the first time that interleukin-11 (IL-11) may be an important therapeutic target for cardiovascular (CV) fibrotic diseases, including heart and renal failure, they reported in the Nov. 13, 2017, edition of Nature.
Read More
View All Articles by John Fox

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 5, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 5, 2026
  • The epidermal growth factor receptor in the inactive (left) and active (right) form.

    Cytospire raises £61M series A to target EGFR in solid tumors

    BioWorld
    Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
  • Strategy compass

    Bio Korea 2026: US policy risks shift to execution framework

    BioWorld
    Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
  • DNA, dollars illustration

    Latus Bio series A financing supports early-stage programs

    BioWorld Science

    Latus Bio Inc. has closed a $97 million series A financing to support its broad therapeutics pipeline based on novel AAV capsid variants. Proceeds from the...

  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing